Enwei Pharmaceutical Statistics

Total Valuation

SHE:301331 has a market cap or net worth of CNY 2.64 billion. The enterprise value is 2.31 billion.

Market Cap	2.64B
Enterprise Value	2.31B

Important Dates

The last earnings date was Monday, April 21, 2025.

Earnings Date	Apr 21, 2025
Ex-Dividend Date	May 23, 2024

Share Statistics

SHE:301331 has 101.08 million shares outstanding. The number of shares has decreased by -1.82% in one year.

Current Share Class	101.08M
Shares Outstanding	101.08M
Shares Change (YoY)	-1.82%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	0.64%
Owned by Institutions (%)	3.40%
Float	24.94M

Valuation Ratios

The trailing PE ratio is 57.80.

PE Ratio	57.80
Forward PE	n/a
PS Ratio	3.20
PB Ratio	2.45
P/TBV Ratio	3.12
P/FCF Ratio	51.47
P/OCF Ratio	27.05
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.48, with an EV/FCF ratio of 45.11.

EV / Earnings	50.96
EV / Sales	2.80
EV / EBITDA	24.48
EV / EBIT	50.49
EV / FCF	45.11

Financial Position

The company has a current ratio of 4.43, with a Debt / Equity ratio of 0.18.

Current Ratio	4.43
Quick Ratio	3.75
Debt / Equity	0.18
Debt / EBITDA	2.09
Debt / FCF	3.86
Interest Coverage	14.72

Financial Efficiency

Return on equity (ROE) is 4.16% and return on invested capital (ROIC) is 2.41%.

Return on Equity (ROE)	4.16%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	2.41%
Return on Capital Employed (ROCE)	3.57%
Revenue Per Employee	533,043
Profits Per Employee	29,314
Employee Count	1,548
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.15% in the last 52 weeks. The beta is 0.61, so SHE:301331's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	-7.15%
50-Day Moving Average	25.47
200-Day Moving Average	24.27
Relative Strength Index (RSI)	50.56
Average Volume (20 Days)	2,683,936

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:301331 had revenue of CNY 825.15 million and earned 45.38 million in profits. Earnings per share was 0.45.

Revenue	825.15M
Gross Profit	410.31M
Operating Income	45.80M
Pretax Income	54.18M
Net Income	45.38M
EBITDA	93.20M
EBIT	45.80M
Earnings Per Share (EPS)	0.45

Full Income Statement

Balance Sheet

The company has 523.32 million in cash and 197.75 million in debt, giving a net cash position of 325.57 million or 3.22 per share.

Cash & Cash Equivalents	523.32M
Total Debt	197.75M
Net Cash	325.57M
Net Cash Per Share	3.22
Equity (Book Value)	1.08B
Book Value Per Share	10.79
Working Capital	729.49M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 97.53 million and capital expenditures -46.27 million, giving a free cash flow of 51.26 million.

Operating Cash Flow	97.53M
Capital Expenditures	-46.27M
Free Cash Flow	51.26M
FCF Per Share	0.51

Full Cash Flow Statement

Margins

Gross margin is 49.73%, with operating and profit margins of 5.55% and 5.50%.

Gross Margin	49.73%
Operating Margin	5.55%
Pretax Margin	6.57%
Profit Margin	5.50%
EBITDA Margin	11.29%
EBIT Margin	5.55%
FCF Margin	6.21%

Dividends & Yields

This stock pays an annual dividend of 0.18, which amounts to a dividend yield of 0.69%.

Dividend Per Share	0.18
Dividend Yield	0.69%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	125.52%
Buyback Yield	1.82%
Shareholder Yield	2.52%
Earnings Yield	1.72%
FCF Yield	1.94%

Dividend Details

Stock Splits

The last stock split was on May 23, 2024. It was a forward split with a ratio of 1.48.

Last Split Date	May 23, 2024
Split Type	Forward
Split Ratio	1.48

Scores

SHE:301331 has an Altman Z-Score of 5.1.

Altman Z-Score	5.1
Piotroski F-Score	n/a